Remote Director, Business Development - EMEA Population Health in Surrey

At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to measure critical protein biomarkers from liquid samples that can enable the earliest possible detection of disease. We believe the next frontier in biology is enabled by measuring proteins at higher sensitivity in highly multiplexed assays at the push of a button, which is something only Alamar can do. As we build our team, we seek collaborative, driven, intellectually curious people committed to solving complex challenges. Our culture rewards accountability and cross-functional teamwork because we believe this enables the kind of breakthrough thinking that will accelerate our mission.

We are seeking a dynamic, collaborative, and results-driven sales professional to join our growing team. Reporting to the Vice President Business Development Global Population Health, you will play a pivotal role in shaping and executing Alamar’s commercial strategy within EMEA while contributing to our global expansion of population health cohorts.

In this field-based role, you will:

• Build Strategic Partnerships: Develop deep, trusted relationships with leading population health cohorts, consortia and organizations they are involved with.
• Drive Market Leadership: Position Alamar’s precision proteomics platforms—NULISA®, NULISAseq™, and ARGO™ HT—as the gold standard for biomarker discovery and translational medicine.
• Accelerate Growth: Lead initiatives that expand our commercial footprint, support organizational scale-up, and consistently achieve or exceed ambitious revenue targets.

This is an opportunity to join a company transforming biomarker-driven healthcare and make a lasting impact on scientific innovation and patient outcomes. Primary responsibilities include:

• Territory Strategy: Lead commercial activities across Europe, the Middle East, and Africa (EMEA), identifying, developing, and expanding strategic relationships with leading population health cohorts, biobanks, academic institutions, research consortiums, and biopharmaceutical organizations.
• Strategic Partnerships: Identify and cultivate strategic collaborations that expand adoption of Alamar technologies within large-scale population health initiatives, national biobanks, research consortiums, and translational medicine partnerships.
• Customer Engagement: Deliver compelling presentations and technical seminars showcasing Alamar’s precision proteomics platforms (NULISA®, NULISAseq™, ARGO™ HT) to educate and inspire customers.
• Consultative Selling: Advise customers on the scientific and clinical value of Alamar technologies for biomarker discovery and translational medicine, ensuring an exceptional customer experience.
• Market Intelligence: Partner cross-functionally to communicate customer insights that inform future product development and market expansion strategies.
• Sales Leadership: Manage complex sales cycles, driving adoption of cutting-edge proteomics solutions in academic, biopharma, and clinical research settings.
• Pipeline Development: Proactively prospect and cultivate new leads to expand Alamar’s presence in key therapeutic areas and open new markets.

Forecasting advanced degree (MBA or equivalent) strongly preferred. Proven Expertise: 8-10 years of successful business development, commercial, account management, or sales leadership experience in life sciences, diagnostics, genomics, proteomics, analytical instruments, or related healthcare technology sectors. Experience selling to or partnering with large-scale population health studies, biobanks, government-funded research initiatives, research consortiums, translational medicine programs, or pharmaceutical research organizations is strongly preferred. Proven ability to operate effectively across multiple countries, cultures, and healthcare ecosystems, building trust with diverse scientific and executive stakeholders. Scientific Acumen: Deep understanding of biomarker discovery, proteomics workflows, and the broader life sciences cohort market landscape. Strategic Mindset: Ability to translate scientific value into commercial impact, driving adoption of cutting-edge technologies in research and clinical settings. Adaptability.